All News

The Working Group examined the insulin supply chain and the factors that impact the costs of and access to insulin products.

Cemiplimab induced a response in approximately half of patients with advanced cutaneous squamous-cell carcinoma.

Researchers studied the effects of an antioxidant-enriched multivitamin on inflammation and health outcomes in patients with cystic fibrosis.

According to a new study, reducing prescription opioid duration, not dosage, may be more effective in curbing misuse after surgery.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape

Allergan announced positive topline results from CGP-MD-01, a phase 2b/3 clinical trial of atogepant.

The CDC and local poison control centers offer useful guidance for best practices.

A significant and positive association has linked common allergic conditions to autism spectrum disorder (ASD) in children.

A study comparing denosumab (Prolia) with risedronate (Actone) found that denosumab could be a useful treatment option for patients newly initiating or continuing glucocorticoids who are at risk of fractures.

Top news of the day from across the health care landscape.

Specialty drugs with limited distribution networks require pharmacies to put together an extensive request for proposal to gain access.

A new study revealed no new or unexpected safety concerns associated with the diphtheria, tetanus, and acellular pertussis vaccine (DTaP).

Top news of the day from across the health care landscape

The researchers found that total duration of opioid use was the strongest predictor of misuse, with each refill and additional week of opioid use associated with an increased rate of misuse.

Officials with the FDA have granted GBC0905, for the treatment of facioscapulohumeral muscular dystrophy (FSHD), an Orphan Drug Designation.

At the American Pharmacy Purchasing Alliance’s PharmCon in Orlando, FL, experts with collaborative practice experience discussed why these pharmacist-physician partnerships are useful, and how they can effectively work.

Individuals who inject drugs are at an increased risk of developing invasive methicillin-resistant Staphylococcus aureus (MRSA).

During a presentation at the American Pharmacy Purchasing Alliance's Pharmacon in Orlando, FL, several panelists discussed the use of nutraceuticals in managing conditions like chronic pain.

Change is needed to create a better working relationship between pharmacy benefit managers (PBMs) and independent pharmacies, according to a panel of experts at the American Pharmacy Purchasing Alliance (APPA) conference in Orlando, FL.

The deaths this week of Kate Spade and Anthony Bourdain have sparked a much-needed public discussion about mental health and suicide can be prevented.

As one of the most accessible health care providers, our patients come to us seeking advice not only for prescription medication and OTC questions but also on the big question: "How do I get healthy?"

An esteemed panel will deliberate more than 600 nominations.

Patients with both private and public insurers face high denial rates across the United States for life-saving hepatitis C drugs, despite changes in restrictions and increased price competition.

Top news of the week from Specialty Pharmacy Times.

Top news of the week from The American Journal of Pharmacy Benefits.

Top news of the day from across the health care landscape

The therapy has been approved to treat pemphigus vulgaris (PV), a condition characterized by progressive blistering of the skin and mucous membranes